Traws Pharma TRAW
NASDAQ TRAW
$0.55 -0.05 (-8.17%)
As of: Oct 1, 2026 · 3:59 PM EDT

Traws Pharma (TRAW) Preferred Stock Liabilities (2012 - 2024)

Updated

Traws Pharma's Preferred Stock Liabilities was $111.62 million in Q2 2024.

Analysis

Traws Pharma (TRAW) Preferred Stock Liabilities (2012 - 2024) Analysis & Trends

At the end of FY2012, Preferred Stock Liabilities at Traws Pharma came in at $201.32 million, up 67.8% from FY2011.

  • In earlier years, Preferred Stock Liabilities was $120 million in FY2011.
  • The Q2 2024 figure marks the highest quarterly Preferred Stock Liabilities since Q2 2013.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Preferred Stock Liabilities (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn -
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn -
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn -
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn -
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn -
10 Traws Pharma 6.00 Mn -12.39 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2024 111.62 Mn
Jun 30, 2013 203.37 Mn
Dec 31, 2012 201.32 Mn
API Access

Traws Pharma Preferred Stock Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=preferred-stock-liabilities&ticker=TRAW&period=max&api_key=YOUR_API_KEY